Fast-track your viral vector bioanalysis using Gyrolab® Systems’ proprietary microfluidic nanoliter-scale, flow-through technology that dramatically reduces sample and reagent volumes and eliminates incubation times, resulting in improved data quality and reproducibility and results within an hour. Reliably monitor AAV-based and lentivirus-based vector manufacturing batch quality and immunogenicity in preclinical and clinical studies using Gyrolab assays and kits. Our peptide synthesis and bioanalytical solutions accelerate the discovery, development, and manufacturing of safer biotherapeutics. Gyros Protein Technologies is a division of Mesa Laboratories. www.gyrosproteintech.com